🇺🇸 FDA
Patent

US 9765142

TEM8 antibodies and their use in treatment and detection of tumors

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 9765142 (TEM8 antibodies and their use in treatment and detection of tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K39/39558, A61K45/06